For educational purposes only. Not medical advice.
⸻
Short Answer
For many experienced users, returning hunger does not automatically mean Retatrutide has stopped working.
Instead, it often means one of three things:
✅ Your body has adapted to your current amount.
✅ Weight loss has slowed into a temporary plateau.
✅ Enough time has passed that an adjustment is needed.
Some members of the peptide community choose to add a small amount of Tirzepatide instead of making a large increase in Retatrutide.
⸻
Why Does Hunger Return?
One of the biggest misconceptions is that hunger suppression should remain constant forever.
It usually doesn’t.
Researchers commonly notice that appetite suppression is strongest during the first several weeks after each increase before gradually becoming less noticeable.
This does not necessarily mean the peptide has stopped working.
Many people continue losing weight even after hunger partially returns because:
* They feel full sooner.
* Blood sugar remains stable.
* Food cravings stay lower than before.
* Their metabolism may still be elevated.
Retatrutide activates three receptors:
* GLP-1
* GIP
* Glucagon
The glucagon receptor appears to contribute to increased energy expenditure, making Retatrutide different from Tirzepatide. (PMC)
⸻
Why Some Users Add Tirzepatide
Across Reddit, Facebook groups, and peptide forums, a common strategy is adding low-dose Tirzepatide when:
* Hunger returns between injections.
* Weight loss has plateaued for several weeks.
* They are already tolerating Retatrutide well.
* They don’t want to immediately increase Retatrutide.
The idea is simple:
Retatrutide already stimulates GLP-1, GIP, and glucagon receptors.
Adding a small amount of Tirzepatide may increase GLP-1 and GIP activity without changing the Retatrutide schedule.
Again, this approach is anecdotal and has not been validated in controlled studies. (Lilly Trials)
⸻
Common Community Approach
Retatrutide remains the primary weekly peptide.
Many community users report taking Retatrutide on the same day each week.
If hunger begins returning several days later, some users choose to add a small Tirzepatide injection 3–4 days after the Retatrutide dose rather than taking both on the same day.
The goal is to provide steadier appetite control throughout the week.
A commonly reported pattern in online communities is:
Monday
* Retatrutide
Thursday or Friday
* Low-dose Tirzepatide
This is based on user experience rather than clinical evidence.
⸻
How Much Tirzepatide Do Users Commonly Add?
Community reports commonly describe starting with a much smaller amount than they would use if taking Tirzepatide by itself.
Instead of beginning with a full Tirzepatide escalation, many users report starting with approximately 1–2.5 mg once weekly, then waiting several weeks before deciding whether any adjustment is needed.
The general philosophy shared online is:
“Start with the smallest amount that restores appetite control.”
More is not always better.
Because both peptides activate GLP-1 and GIP pathways, increasing too aggressively may increase gastrointestinal side effects without providing additional benefit.
⸻
Should You Increase Retatrutide Instead?
Many experienced users recommend asking these questions first:
✅ Have I stayed at my current Retatrutide amount for at least 4 weeks?
✅ Am I still losing inches or weight?
✅ Am I still getting full faster?
✅ Are cravings still lower than before treatment?
If the answer is yes, increasing or adding another peptide may not yet be necessary.
Sometimes patience works better than chasing stronger appetite suppression.
⸻
Possible Downsides
Adding Tirzepatide may increase the likelihood of:
* Nausea
* Constipation
* Diarrhea
* Vomiting
* Reflux
* Fatigue
* Reduced food intake
* Difficulty consuming enough protein
These side effects are well recognized with GLP-1–based therapies and may become more pronounced when receptor stimulation is increased. (PMC)
⸻
Tips If Hunger Returns
Before adding another peptide, many users first try:
✔️ Increasing daily protein.
✔️ Drinking more water.
✔️ Improving sleep.
✔️ Adding resistance training.
✔️ Eating larger meals earlier in the day.
✔️ Waiting another 1–2 weeks to see whether weight loss resumes.
Sometimes hunger returns before the scale begins moving again.
⸻
Bottom Line
Retatrutide remains one of the most powerful investigational metabolic peptides because it activates GLP-1, GIP, and glucagon receptors.
Although some users report improved appetite control by adding a small Tirzepatide dose midway through the week, there are currently no clinical studies demonstrating that this combination is safe or more effective than Retatrutide alone.
For that reason, any combination strategy should be viewed as experimental rather than evidence-based.
⸻
References
* Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity. New England Journal of Medicine.
* Recent reviews on dual and triple incretin agonists (2024–2025).
* Community anecdotal reports from online GLP-1 and peptide discussion forums (non-peer-reviewed).